TITLE

Autoinsertion of soluble oligomers of Alzheimer's Aβ(1--42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface

PUB. DATE
January 2006
SOURCE
BMC Structural Biology;2006, Vol. 6, p21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43715931

 

Related Articles

  • Aggregation of Aß(25-35) on DOPC and DOPC/DHA Bilayers: An Atomic Force Microscopy Study. Sublimi Saponetti, Matilde; Grimaldi, Manuela; Scrima, Mario; Albonetti, Cristiano; Nori, Stefania Lucia; Cucolo, Annamaria; Bobba, Fabrizio; D'Ursi, Anna Maria // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    β amyloid peptide plays an important role in both the manifestation and progression of Alzheimer disease. It has a tendency to aggregate, forming low-molecular weight soluble oligomers, higher-molecular weight protofibrillar oligomers and insoluble fibrils. The relative importance of these...

  • Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Ramachandran, Rajesh; Heuck, Alejandro P.; Tweten, Rodney K.; Johnson, Arthur E. // Nature Structural Biology;Nov2002, Vol. 9 Issue 11, p823 

    Perfringolysin O (PFO), a cytolytic toxin secreted by pathogenic Clostridium perfringens, forms large pores in cholesterol-containing membranes. Domain 4 (D4) of the protein interacts first with the membrane and is responsible for cholesterol recognition. By using several independent...

  • Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer’s-Associated Aβ Oligomers. Wilcox, Kyle C.; Marunde, Matthew R.; Das, Aditi; Velasco, Pauline T.; Kuhns, Benjamin D.; Marty, Michael T.; Jiang, Haoming; Luan, Chi-Hao; Sligar, Stephen G.; Klein, William L. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Despite their value as sources of therapeutic drug targets, membrane proteomes are largely inaccessible to high-throughput screening (HTS) tools designed for soluble proteins. An important example comprises the membrane proteins that bind amyloid β oligomers (AβOs). AβOs are neurotoxic...

  • Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes. Preu, Julia; Jaeger, Timo; Garamus, Vasil; Gutberlet, Thomas // European Biophysics Journal;May2011, Vol. 40 Issue 5, p687 

    Understanding biological processes assumes a detailed understanding of the interaction of all involved molecules. Here the effect of the peptide hormone angiotensin II (Ang II), an agonist of the angiotensin receptors, on the structure of unilamellar and multilamellar dimyristoyl...

  • Investigation of membrane penetration depth and interactions of the amino-terminal domain of huntingtin: refined analysis by tryptophan fluorescence measurement. Michalek, Matthias; Aisenbrey, Christopher; Bechinger, Burkhard // European Biophysics Journal;Sep2014, Vol. 43 Issue 8/9, p347 

    The membrane-association properties of the amino-terminal domain of huntingtin are accompanied by subcellular redistribution of the protein in cellular compartments. In this study we used tryptophan substitution of amino-acid residues at different positions of the huntingtin 1-17 domain (Htt17)...

  • The Position of Aβ22-40 and Aβ1-42 in Anionic Lipid Membranes Containing Cholesterol. Barrett, Matthew A.; Alsop, Richard J.; Hauß, Thomas; Rheinstädter, Maikel C. // Membranes;2015, Vol. 5 Issue 4, p824 

    Amyloid-β peptides interact with cell membranes in the human brain and are associated with neurodegenerative diseases, such as Alzheimer's disease. An emerging explanation of the molecular mechanism, which results in neurodegeneration, places the cause of neurotoxicity of the amyloid-β...

  • Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Laurén, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M. // Nature;2/26/2009, Vol. 457 Issue 7233, p1128 

    A pathological hallmark of Alzheimer’s disease is an accumulation of insoluble plaque containing the amyloid-β peptide of 40–42 amino acid residues. Prefibrillar, soluble oligomers of amyloid-β have been recognized to be early and key intermediates in...

  • Free energy simulations of amylin I26P mutation in a lipid bilayer. Jalili, Seifollah; Maleki, Afsaneh; Akhavan, Mojdeh; Najafi, Bijan; Schofield, Jeremy // European Biophysics Journal;Feb2015, Vol. 44 Issue 1/2, p37 

    The amylin peptide in a dioleoylphosphatidylcholine (DOPC) bilayer is studied using united atom molecular dynamics (MD) simulations. Dynamics and transport properties of the peptide and the phospholipid bilayer are investigated. The lateral diffusion of DOPC is in the order of 10 cm s, which is...

  • Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Bram, Yaron; Frydman-Marom, Anat; Yanai, Inbal; Gilead, Sharon; Shaltiel-Karyo, Ronit; Amdursky, Nadav; Gazit, Ehud // Scientific Reports;3/7/2014, p1 

    Soluble oligomeric assemblies of amyloidal proteins appear to act as major pathological agents in several degenerative disorders. Isolation and characterization of these oligomers is a pivotal step towards determination of their pathological relevance. Here we describe the isolation of Type 2...

  • BACE Inhibitors as Potential Therapeutics for Alzheimer's disease. Evin, Genevieve; Kenche, Vijaya B. // Recent Patents on CNS Drug Discovery;Nov2007, Vol. 2 Issue 3, p188 

    Accumulation of A� peptide in the brain results in the formation of amyloid plaques characteristic of Alzheimer's disease (AD) pathology. A� soluble oligomers and protofibrils are neurotoxic and these are believed to be a major cause of neurodegeneration in AD. A� is derived from...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics